ArticleHemaSphere2024

IDALLO study: A retrospective multicenter study of the SFGM-TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1-mutated AML after allogeneic hematopoietic cell transplantation.

Adrien Caillet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.